Tylosin

Tylosin is a lipid of Polyketides (PK) class. Tylosin is associated with abnormalities such as Mastitis, Bovine, Infection, Bacterial Infections, Arthritis and Ileitis. The involved functions are known as Anabolism, acireductone dioxygenase [iron(II)-requiring] activity, Protein Biosynthesis, Mastitis and Methylation. Tylosin often locates in Ribosomes, Cell Wall, 50S ribosomal subunit, Ribosome Subunits, Large and Ribosome Subunits. The associated genes with Tylosin are Gene Clusters, Genome, resistance genes, Homologous Gene and HM13 gene. The related experimental models are Knock-out.

Cross Reference

Introduction

To understand associated biological information of Tylosin, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.

What diseases are associated with Tylosin?

Tylosin is suspected in Porcine ulcerative spirochetosis, Infection, Liver Abscess, Respiration Disorders, Intestinal Diseases, Mastitis, Bovine and other diseases in descending order of the highest number of associated sentences.

Related references are mostly published in these journals:

Disease Cross reference Weighted score Related literature
Loading... please refresh the page if content is not showing up.

Possible diseases from mapped MeSH terms on references

We collected disease MeSH terms mapped to the references associated with Tylosin

MeSH term MeSH ID Detail
Diarrhea D003967 32 associated lipids
Dysentery D004403 4 associated lipids
Enterotoxemia D004767 1 associated lipids
Erysipelothrix Infections D004889 1 associated lipids
Facial Dermatoses D005148 7 associated lipids
Foreign Bodies D005547 5 associated lipids
Hemolysis D006461 131 associated lipids
Hyperplasia D006965 34 associated lipids
Keratoconjunctivitis, Infectious D007639 2 associated lipids
Liver Abscess D008100 6 associated lipids
Per page 10 20 50 | Total 47

PubChem Associated disorders and diseases

What pathways are associated with Tylosin

There are no associated biomedical information in the current reference collection.

PubChem Biomolecular Interactions and Pathways

Link to PubChem Biomolecular Interactions and Pathways

What cellular locations are associated with Tylosin?

Related references are published most in these journals:

Location Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What functions are associated with Tylosin?


Related references are published most in these journals:

Function Cross reference Weighted score Related literatures

What lipids are associated with Tylosin?

There are no associated biomedical information in the current reference collection.

What genes are associated with Tylosin?

Related references are published most in these journals:


Gene Cross reference Weighted score Related literatures

What common seen animal models are associated with Tylosin?

Knock-out

Knock-out are used in the study 'A second tylosin resistance determinant, Erm B, in Arcanobacterium pyogenes.' (Jost BH et al., 2004).

Related references are published most in these journals:

Model Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

NCBI Entrez Crosslinks

All references with Tylosin

Download all related citations
Per page 10 20 50 100 | Total 931
Authors Title Published Journal PubMed Link
Narandja A et al. Structure-activity relationship among polyhydro derivatives of tylosin. 1994 J. Antibiot. pmid:8040056
Creemer LC et al. Facile synthesis of tilmicosin and tylosin related haptens for use as protein conjugates. 2003 J. Antibiot. pmid:12870814
Bobillot S et al. Chemical modification of tylosin. 1995 J. Antibiot. pmid:7649866
Creemer LC et al. Synthesis, antimicrobial activity and in vivo fluorine NMR of a hexafluorinated derivative of tilmicosin. 1995 J. Antibiot. pmid:7649867
Narandja A et al. 10,11,12,13-Tetrahydro derivatives of tylosin. II. Synthesis, antibacterial activity and tissue of 4'-deoxy-10,11,12,13-tetrahydrodesmycosin. 1995 J. Antibiot. pmid:7730160
Arisawa A et al. Direct fermentative production of acyltylosins by genetically-engineered strains of Streptomyces fradiae. 1996 J. Antibiot. pmid:8641997
Mandić Z et al. Tylosin derivatives. V. Electrochemical opening of oxirane ring. 1999 J. Antibiot. pmid:10695679
Kageyama S and Tsuchiya T Synthesis of 2-C-methyl derivatives of 3,4'-dideoxymycaminosyltylonolide, a novel type of 16-membered macrolide antibiotic. 1994 J. Antibiot. pmid:7928687
Terui Y et al. Synthesis of 2-methyl 16-membered macrolide derived from tylosin. 2006 J. Antibiot. pmid:16629410
Baltz RH et al. Biosynthesis of the macrolide antibiotic tylosin. A preferred pathway from tylactone to tylosin. 1983 J. Antibiot. pmid:6833128
Omura S et al. Chimeramycins: new macrolide antibiotics produced by hybrid biosynthesis. 1983 J. Antibiot. pmid:6860432
Tsuchiya M et al. Binding of 3-O-acetyl-4"-O-isovaleryltylosin to ribosomes from a macrolide-resistant strain of Staphylococcus aureus. 1982 J. Antibiot. pmid:7118723
Sugawara A et al. 5-O-Mycaminosyltylonolide antibacterial derivatives: design, synthesis and bioactivity. 2017 J. Antibiot. pmid:28559578
Sakamoto S et al. Syntheses of 23-deoxy-23-N-ethyl-23-(2-fluoro-, 2,2-difluoro-, and 2,2,2-trifluoroethyl)amino derivatives of mycaminosyl tylonolide and 4'-deoxymycaminosyl tylonolide. 1984 J. Antibiot. pmid:6526731
Mutoh Y et al. Deepoxidation of 16-membered epoxyenone macrolide antibiotics. II. Chemical deepoxidation by dissolving metal reduction. 1984 J. Antibiot. pmid:6706848
Sakamoto M et al. Deepoxidation of 16-membered epoxyenone macrolide antibiotics. III. In vitro and in vivo evaluation of deepoxidation products of carbomycin A, deltamycin A1, 4"-phenylacetyldeltamycin, angolamycin and rosamicin. 1984 J. Antibiot. pmid:6706849
Omura S et al. Ribosome-binding activities and antimicrobial activities of tylosin and its related compounds. 1983 J. Antibiot. pmid:6662812
Matsubara H et al. Chemical modification of tylosin: synthesis of amino derivatives at C-20 position of tylosin and demycarosyltylosin. 1983 J. Antibiot. pmid:6662813
Omura S et al. Ammonium ion suppresses the biosynthesis of tylosin aglycone by interference with valine catabolism in Streptomyces fradiae. 1983 J. Antibiot. pmid:6662823
Lee BK et al. Multistep bioconversion of 20-deoxo-20-dihydro-12,13-deepoxy-12,13-dehydrorosaranolide to 22-hydroxy-23-O-mycinosyl-20-deoxo-20-dihydro-12,13-deepoxy-rosaramicin. 1983 J. Antibiot. pmid:6874596
Sadakane N et al. Hybrid biosynthesis of a new macrolide antibiotic by a daunomycin-producing microorganism. 1983 J. Antibiot. pmid:6885644
Tsutsui A et al. Antimalarial C-9 oxime derivatives from desmycosin, produced by click chemistry. 2013 J. Antibiot. pmid:23232930
Norcia LJ et al. In vitro microbiological characterization of novel macrolide CP-163,505 for animal health specific use. 1998 J. Antibiot. pmid:9544934
Kageyama S et al. Synthesis of 3,4'-dideoxymycaminosyl tylonolide, a novel type of macrolide derivative. 1992 J. Antibiot. pmid:1548187
Fujiwara T et al. Absorption, tissue distribution and excretion of 19-deformyldesmycosin derivatives, new 16-membered macrolides, in mice. 1990 J. Antibiot. pmid:2324015
Debono M et al. Synthesis and antimicrobial evaluation of 20-deoxo-20-(3,5-dimethylpiperidin-1-yl)desmycosin (tilmicosin, EL-870) and related cyclic amino derivatives. 1989 J. Antibiot. pmid:2668243
Omura S et al. Effect of ammonium ion, inorganic phosphate and amino acids on the biosynthesis of protylonolide, a precursor of tylosin aglycone. 1984 J. Antibiot. pmid:6735923
Omura S et al. Valine as a precursor of n-butyrate unit in the biosynthesis of macrolide aglycone. 1983 J. Antibiot. pmid:6874580
Butler AR et al. Influence of ancillary genes, encoding aspects of methionine metabolism, on tylosin biosynthesis in Streptomyces fradiae. 2001 J. Antibiot. pmid:11594346
Baltz RH and Stonesifer J Phenotypic changes associated with loss of expression of tylosin biosynthesis and resistance genes in Streptomyces fradiae. 1985 J. Antibiot. pmid:4066505
Jacob ME et al. Effects of feeding wet corn distillers grains with solubles with or without monensin and tylosin on the prevalence and antimicrobial susceptibilities of fecal foodborne pathogenic and commensal bacteria in feedlot cattle. 2008 J. Anim. Sci. pmid:18192558
Maxwell CL et al. The effects of technology use in feedlot production systems on feedlot performance and carcass characteristics. 2015 J. Anim. Sci. pmid:26020911
Pilcher CM et al. The interaction of fiber, supplied by distillers dried grains with solubles, with an antimicrobial and a nutrient partitioning agent on nitrogen balance, water utilization, and energy digestibility in finishing pigs. 2015 J. Anim. Sci. pmid:26020889
Mercadante VR et al. Effects of anti-phospholipase A(2) antibody supplementation on dry matter intake feed efficiency, acute phase response, and blood differentials of steers fed forage- and grain-based diets. 2015 J. Anim. Sci. pmid:26020758
Maxwell CL et al. Effects of beef production system on animal performance and carcass characteristics. 2014 J. Anim. Sci. pmid:25403195
Tennant TC et al. Comparison of tulathromycin and tilmicosin on the prevalence and severity of bovine respiratory disease in feedlot cattle in association with feedlot performance, carcass characteristics, and economic factors. 2014 J. Anim. Sci. pmid:25349362
Beck P et al. Additive effects of growth promoting technologies on performance of grazing steers and economics of the wheat pasture enterprise. 2014 J. Anim. Sci. pmid:24492552
DiLorenzo N et al. Effects of feeding polyclonal antibody preparations on ruminal bacterial populations and ruminal pH of steers fed high-grain diets. 2006 J. Anim. Sci. pmid:16864880
Abell KM et al. A mixed treatment comparison meta-analysis of metaphylaxis treatments for bovine respiratory disease in beef cattle. 2017 J. Anim. Sci. pmid:28380607
Bosi P et al. Feed supplemented with 3 different antibiotics improved food intake and decreased the activation of the humoral immune response in healthy weaned pigs but had differing effects on intestinal microbiota. 2011 J. Anim. Sci. pmid:21724943
Cooprider KL et al. Feedlot efficiency implications on greenhouse gas emissions and sustainability. 2011 J. Anim. Sci. pmid:21398565
Nagaraja TG and Chengappa MM Liver abscesses in feedlot cattle: a review. 1998 J. Anim. Sci. pmid:9464910
Meyer NF et al. Effect of essential oils, tylosin, and monensin on finishing steer performance, carcass characteristics, liver abscesses, ruminal fermentation, and digestibility. 2009 J. Anim. Sci. pmid:19359504
Galyean ML et al. Effects of arrival medication with tilmicosin phosphate on health and performance of newly received beef cattle. 1995 J. Anim. Sci. pmid:7665351
Clary EM et al. Supplemental fat and ionophores in finishing diets: feedlot performance and ruminal digesta kinetics in steers. 1993 J. Anim. Sci. pmid:8270535
Weber TE and Kerr BJ Effect of sodium butyrate on growth performance and response to lipopolysaccharide in weanling pigs. 2008 J. Anim. Sci. pmid:17998428
Effect of space allowance and tylosin feeding on performance of growing-finishing pigs. NCR-89 Committee on Confinement Management of Swine. 1986 J. Anim. Sci. pmid:3710927
Brumm MC et al. Effect of wean-to-finish management on pig performance. 2002 J. Anim. Sci. pmid:11881920
Han H et al. Carbohydrate fermentation and nitrogen metabolism of a finishing beef diet by ruminal microbes in continuous cultures as affected by ethoxyquin and(or) supplementation of monensin and tylosin. 2002 J. Anim. Sci. pmid:12002320
Galyean ML et al. Performance of feedlot steers fed diets containing laidlomycin propionate or monensin plus tylosin, and effects of laidlomycin propionate concentration on intake patterns and ruminal fermentation in beef steers during adaptation to a high-concentrate diet. 1992 J. Anim. Sci. pmid:1429270